{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:43:54Z","timestamp":1762145034452},"reference-count":74,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.semnephrol.2014.04.009","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T02:15:45Z","timestamp":1397614545000},"page":"340-348","source":"Crossref","is-referenced-by-count":7,"title":["Increased Aldosterone: Mechanism of Hypertension in Obesity"],"prefix":"10.1016","volume":"34","author":[{"given":"Colleen","family":"Flynn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2014.04.009_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","article-title":"Prevalence and trends in obesity among US adults, 1999-2008","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jch.12049","article-title":"Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension","volume":"15","author":"Landsberg","year":"2013","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000175868","article-title":"Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts","volume":"82","author":"Stamler","year":"1993","journal-title":"Cardiology"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7326\/0003-4819-67-1-48","article-title":"The relation of adiposity to blood pressure and development of hypertension. The Framingham study","volume":"67","author":"Kannel","year":"1967","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib5","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/bmj.289.6454.1257","article-title":"Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden","volume":"289","author":"Lapidus","year":"1984","journal-title":"Br Med J"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib6","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/bmj.288.6428.1401","article-title":"Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913","volume":"288","author":"Larsson","year":"1984","journal-title":"Br Med J"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib7","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.35.5.1135","article-title":"Weight gain-induced blood pressure elevation","volume":"35","author":"Masuo","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib8","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1038\/oby.2007.358","article-title":"Cardiorespiratory fitness influences the blood pressure response to experimental weight gain","volume":"15","author":"Gentile","year":"2007","journal-title":"Obesity"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.amjhyper.2006.01.012","article-title":"Prehypertension and obesity in adolescents: a population study","volume":"19","author":"Israeli","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib10","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/ijo.2012.32","article-title":"Obesity is a strong determinant of hypertensive target organ damage in young-to-middle-age patients","volume":"37","author":"Palatini","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/HJH.0b013e32835a3637","article-title":"Obesity phenotype and incident hypertension: a prospective community-based cohort study","volume":"31","author":"Lee","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib12","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMoa035622","article-title":"Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery","volume":"351","author":"Sjostrom","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib13","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1097\/SLA.0b013e3182a5034b","article-title":"Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus","volume":"258","author":"Brethauer","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib14","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.soard.2013.04.001","article-title":"Metabolic syndrome, hypertension, and diabetes mellitus after gastric banding: the role of aging and of duration of obesity","volume":"9","author":"Pontiroli","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/01.HYP.30.5.1144","article-title":"Insulin resistance, hyperinsulinemia, and blood pressure: role of age and obesity. European Group for the Study of Insulin Resistance (EGIR)","volume":"30","author":"Ferrannini","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1573399810602040367","article-title":"Metabolic obesity: the paradox between visceral and subcutaneous fat","volume":"2","author":"Hamdy","year":"2006","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib17","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib18","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jaci.2005.02.023","article-title":"Adipose tissue, adipokines, and inflammation","volume":"115","author":"Fantuzzi","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib19","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","article-title":"Bariatric surgery: a systematic review and meta-analysis","volume":"292","author":"Buchwald","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib20","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1161\/CIRCULATIONAHA.104.519652","article-title":"Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years","volume":"111","author":"Masuo","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib21","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1124\/mol.56.1.31","article-title":"Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription","volume":"56","author":"Xie","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00008571-199606000-00007","article-title":"Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders","volume":"6","author":"Lachman","year":"1996","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib23","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.metabol.2008.01.012","article-title":"Catechol O-methyltransferase val158-met polymorphism is associated with abdominal obesity and blood pressure in men","volume":"57","author":"Annerbrink","year":"2008","journal-title":"Metabolism"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib24","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.jhh.1002040","article-title":"Association between the Pro12Ala variant of the peroxisome proliferator-activated receptor-gamma2 gene and increased 24-h diastolic blood pressure in obese patients with type II diabetes","volume":"20","author":"Stefanski","year":"2006","journal-title":"J Human Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib25","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11906-013-0330-y","article-title":"Aldosterone and the risk of hypertension","volume":"15","author":"Xanthakis","year":"2013","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib26","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mce.2011.07.034","article-title":"Acute and chronic regulation of aldosterone production","volume":"350","author":"Hattangady","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib28","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000345243","article-title":"Vascular actions of aldosterone","volume":"50","author":"Briet","year":"2013","journal-title":"J Vasc Res"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/ajh.2011.245","article-title":"Mineralocorticoid receptor-associated hypertension and its organ damage: clinical relevance for resistant hypertension","volume":"25","author":"Shibata","year":"2012","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib30","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cjca.2012.03.010","article-title":"Resistant hypertension and aldosterone: an update","volume":"28","author":"Clark","year":"2012","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-138-1-200301070-00007","article-title":"Genetic variation in the renin-angiotensin system and abdominal adiposity in men: the Olivetti Prospective Heart Study","volume":"138","author":"Strazzullo","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0002-8703(02)00132-1","article-title":"Association of angiotensin-converting enzyme DD genotype with blood pressure sensitivity to weight loss","volume":"144","author":"Kostis","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11906-008-0042-x","article-title":"Obesity, sleep apnea, aldosterone, and hypertension","volume":"10","author":"Goodfriend","year":"2008","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib34","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1381\/0960892053923734","article-title":"Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis","volume":"15","author":"Ruano","year":"2005","journal-title":"Obes Surg"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/ajh\/7.4.314","article-title":"Central obesity and hypertension. Relationship between fasting serum insulin, plasma renin activity, and diastolic blood pressure in young obese subjects","volume":"7","author":"Licata","year":"1994","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib36","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.numecd.2008.06.001","article-title":"Effect of weight loss through laparoscopic gastric banding on blood pressure, plasma renin activity and aldosterone levels in morbid obesity","volume":"19","author":"Dall\u05f3Asta","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib37","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/01.HYP.0000154361.47683.d3","article-title":"Weight loss and the renin-angiotensin-aldosterone system","volume":"45","author":"Engeli","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib38","first-page":"I20","article-title":"Salt-regulating hormones in young normotensive obese subjects","volume":"23","author":"Licata","year":"1994","journal-title":"Effects of saline load. Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib39","doi-asserted-by":"crossref","first-page":"789","DOI":"10.3109\/07435809809032689","article-title":"Aldosterone in obesity","volume":"24","author":"Goodfriend","year":"1998","journal-title":"Endocr Res"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib40","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.numecd.2006.07.005","article-title":"The link between abdominal obesity, metabolic syndrome and cardiovascular disease","volume":"17","author":"Ritchie","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","article-title":"Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study","volume":"116","author":"Fox","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib42","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.semnephrol.2007.07.009","article-title":"The association of aldosterone with obesity-related hypertension and the metabolic syndrome","volume":"27","author":"Vogt","year":"2007","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib43","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1161\/01.HYP.0000113294.06704.64","article-title":"Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion","volume":"43","author":"Goodfriend","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib44","doi-asserted-by":"crossref","first-page":"14211","DOI":"10.1073\/pnas.2336140100","article-title":"Human adipocytes secrete mineralocorticoid-releasing factors","volume":"100","author":"Ehrhart-Bornstein","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib45","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/sj.ijo.0803508","article-title":"Adipocyte-derived products induce the transcription of the StAR promoter and stimulate aldosterone and cortisol secretion from adrenocortical cells through the Wnt-signaling pathway","volume":"31","author":"Schinner","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib46","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/00004872-199917040-00014","article-title":"Co-expression of renin-angiotensin system genes in human adipose tissue","volume":"17","author":"Engeli","year":"1999","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib47","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1210\/endo.132.6.8504747","article-title":"Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes","volume":"132","author":"Rondinone","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib48","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1096\/fj.01-0457fje","article-title":"Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation","volume":"15","author":"Massiera","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib49","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/diabetes.54.5.1364","article-title":"The contribution of visceral adipose tissue to splanchnic cortisol production in healthy humans","volume":"54","author":"Andrew","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib50","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1210\/jc.2004-0153","article-title":"Overexpression of 11beta-hydroxysteroid dehydrogenase-1 in adipose tissue is associated with acquired obesity and features of insulin resistance: studies in young adult monozygotic twins","volume":"89","author":"Kannisto","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib51","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib52","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCULATIONAHA.106.648642","article-title":"Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study","volume":"115","author":"Lloyd-Jones","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1467-789X.2011.00914.x","article-title":"Mechanisms linking obesity to hypertension","volume":"13","author":"Dorresteijn","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.semnephrol.2012.12.009","article-title":"Treatment of arterial hypertension in obese patients","volume":"33","author":"Wenzel","year":"2013","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib55","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3810\/pgm.2012.01.2519","article-title":"Recent advancements in the treatment of resistant hypertension","volume":"124","author":"Clark","year":"2012","journal-title":"Postgrad Med"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib56","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.HYP.0000259805.18468.8c","article-title":"Effect of spironolactone on blood pressure in subjects with resistant hypertension","volume":"49","author":"Chapman","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib57","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.amjhyper.2005.11.016","article-title":"Efficacy of add-on aldosterone receptor blocker in uncontrolled hypertension","volume":"19","author":"Sharabi","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib58","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0895-7061(01)02342-1","article-title":"The role of spironolactone in the treatment of patients with refractory hypertension","volume":"15","author":"Ouzan","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib59","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/01.HYP.0000179582.42830.1d","article-title":"Improvement in blood pressure with inhibition of the epithelial sodium channel in blacks with hypertension","volume":"46","author":"Saha","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000060163","article-title":"Angiotensin-converting enzyme inhibitors and progression of renal disease: evidence from clinical studies","volume":"135","author":"Wenzel","year":"2001","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib61","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2165\/00003495-200464220-00004","article-title":"Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system","volume":"64","author":"Scheen","year":"2004","journal-title":"Drugs"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib62","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00004872-200104000-00001","article-title":"Choice of drug treatment for obesity-related hypertension: where is the evidence?","volume":"19","author":"Sharma","year":"2001","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib63","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1161\/01.HYP.38.3.705","article-title":"Treatment of obesity hypertension and diabetes syndrome","volume":"38","author":"Zanella","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib64","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahlof","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib65","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib66","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2215\/CJN.01201005","article-title":"Direct renin inhibition with aliskiren in hypertension and target organ damage","volume":"1","author":"Muller","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib67","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/HJH.0b013e32834f6b43","article-title":"Aliskiren penetrates adipose and skeletal muscle tissue and reduces renin-angiotensin system activity in obese hypertensive patients","volume":"30","author":"Boschmann","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib68","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/eurjhf\/hfs033","article-title":"ALTITUDE, and the implications for ATMOSPHERE","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib69","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MNH.0b013e328350261b","article-title":"AT2 receptor agonists: hypertension and beyond","volume":"21","author":"Steckelings","year":"2012","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib70","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00045415-200205000-00001","article-title":"Clinical management of the obese hypertensive patient","volume":"10","author":"Frohlich","year":"2002","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib71","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib72","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1097\/HJH.0b013e328359862d","article-title":"Association of elevated plasma aldosterone-to-renin ratio with future cardiovascular events in patients with essential hypertension","volume":"30","author":"Kisaka","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib73","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archinte.168.6.571","article-title":"Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis","volume":"168","author":"Horvath","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.semnephrol.2014.04.009_bib74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-134-1-200101020-00007","article-title":"Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II","volume":"134","author":"Stevens","year":"2001","journal-title":"Ann Intern Med"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929514000515?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929514000515?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T11:37:43Z","timestamp":1565350663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929514000515"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":74,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0270929514000515"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2014.04.009","relation":{},"ISSN":["0270-9295"],"issn-type":[{"type":"print","value":"0270-9295"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}